Moichor
Moichor is a San Francisco-based veterinary diagnostics company that sells Pathview, an AI-powered point-of-care hematology and cytology system trained on 2M+ pathology objects across 350+ species, serving companion animal practices, exotic animal hospitals, and emergency veterinary settings with a hybrid hardware, consumables, and reference lab model.
- Company typePrivate
- Founded2019
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Moichor does
Moichor Inc. is a San Francisco-based veterinary diagnostics company founded in 2019 that builds AI-powered point-of-care and reference lab tools for animal health. Its core product, Pathview, is described as the first image-based complete blood count (CBC) device in the veterinary market; it uses computer vision algorithms trained on more than 2 million pathology objects spanning over 350 species to deliver preliminary hematology and cytology results in as little as 15 minutes, with board-certified pathologist review available on a STAT basis within two hours. The company also operates a Reference Lab service that provides remote pathology interpretation to clinics without in-house Pathview systems.
The business operates a hybrid revenue model combining hardware sales of Pathview systems, recurring consumables revenue tied to each device placement, and professional pathology services. Pricing is not publicly disclosed, though the company claims average cost savings of 35%+ versus traditional reference lab testing. Moichor serves two primary customer segments: companion animal practices (dogs and cats) and exotic animal hospitals (birds, reptiles, ferrets, and other non-traditional pets), with secondary exposure to point-of-care emergency settings. Named customers include specialty providers such as MedVet, GCVS Healthcare, and NorthStar VETS, alongside mid-market general practice and exotic clinics.
Moichor distributes directly through its own sales motion and demo-request funnel, and — as of a February 2026 commercial agreement — through a channel partnership with Zomedica Corp. to sell co-branded TRUVIEW digital microscopy systems integrated with Moichor's AI engine and pathology services across the United States. The company has raised approximately $4 million in disclosed seed funding (led by Neotribe Ventures with Y Combinator participation in April 2021) and operates with 11–50 employees. It is privately held with no parent company and no public listing.
Moichor firmographics
Firmographics- Name
- Moichor
- Legal name
- Moichor Inc.
- Website
- https://Moichor.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Moichor is a San Francisco-based veterinary diagnostics company that sells Pathview, an AI-powered point-of-care hematology and cytology system trained on 2M+ pathology objects across 350+ species, serving companion animal practices, exotic animal hospitals, and emergency veterinary settings with a hybrid hardware, consumables, and reference lab model.
- Ownership category
- akta.pro rank
Moichor industry classification
Industry- Product category
- Veterinary Diagnostics Software
- NAICS
- Veterinary Services (541940), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI)
- akta.pro secondary industries
- Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA), Veterinary Lab/Imaging Integration & LIS/PACS Connectivity (HLAMAMAG), Veterinary Diagnostic Laboratories & Pathology (AFAEANAF)
Keywords
Where Moichor is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Moichor business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Pathview System Sales: Sale of AI-powered Pathview image-based CBC and cytology devices to veterinary clinics. First commercially available devices began shipping September 2022.
- Recurring Consumables Revenue: Each TRUVIEW system placement generates recurring consumables revenue as system placements grow across customer network. Consumables include testing supplies and reagents needed for diagnostic tests.
- Pathology Services: Board-certified pathology services integrated with AI engine, providing expert interpretation of diagnostic results for veterinary practices.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Moichor product offering
Product offeringCore offering
Moichor sells an AI-assisted hematology and cytology point-of-care diagnostic system (Pathview) for veterinary clinics, using computer vision trained on over 2 million pathology objects spanning 350+ species to deliver preliminary diagnostic results in 15 minutes. The company also operates a veterinary Reference Lab service providing board-certified pathology expertise for clinics without in-house Pathview systems.
Product overview
Moichor offers AI-powered veterinary diagnostic products centered on its Pathview platform — an AI-assisted hematology and cytology system for point-of-care clinics — complemented by a Reference Lab service that provides remote pathology expertise. Both products leverage computer vision trained on millions of pathology samples to deliver rapid diagnostic results within 15 minutes, supporting CBC and cytology evaluation across more than 350 species including companion animals, birds, reptiles, and exotic animals.
Differentiator
Problem solved
Functional benefit
Brands
- Pathview: AI-assisted hematology and cytology system for veterinary clinics, providing pathologist-level results assisted by AI with results in as little as 15 minutes.
- Reference Lab
Products and services
- Pathview AI-assisted hematology and cytology system designed for point-of-care veterinary clinics. Provides pathologist-level results in as little as 15 minutes, performing CBC and cytology evaluation for any species including companion animals, birds, reptiles, and exotic animals.
- Reference Lab Veterinary pathology services providing access to board-certified pathology expertise for clinics that do not have in-house Pathview systems, offering comprehensive diagnostic support for veterinary practices nationwide.
Quantifiable outcome
- 35%+ average cost savings for veterinary clinics
- +3 more outcomes
Companies that use Moichor
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Moichor technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
Moichor partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ZomedicacoreCommercial distribution agreement under which Zomedica supplies its TRUVIEW digital microscopy systems and associated testing supplies for Moichor's sale to point-of-care veterinary customers nationwide. The co-branded systems integrate Moichor's proprietary AI engine and board-certified pathology services, expanding the TRUVIEW platform's reach into companion animal practices and exotic animal hospitals. Each system placement is expected to generate recurring consumables revenue.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Moichor competitors and assessment
Company assessmentMarket position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Moichor social profiles
Digital presenceMoichor financial estimates
Financial estimateRevenue estimate
Valuation estimate
Moichor leadership team
Management profileNumber of profiles
Profiles6 records
Moichor funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Moichor M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Moichor
What does Moichor do?
Moichor sells an AI-assisted hematology and cytology point-of-care diagnostic system (Pathview) for veterinary clinics, using computer vision trained on over 2 million pathology objects spanning 350+ species to deliver preliminary diagnostic results in 15 minutes. The company also operates a veterinary Reference Lab service providing board-certified pathology expertise for clinics without in-house Pathview systems.
Is Moichor a public or private company?
Moichor is a private company. It is classified as venture growth investor backed and is currently operating.
When was Moichor founded?
Moichor was founded in 2019. It employs 11 to 50 people.
Where is Moichor based?
Moichor is headquartered in San Francisco, United States, in the North America region.
How does Moichor make money?
Three revenue lines are on record. Pathview System Sales are the primary driver. The others are recurring Consumables Revenue and pathology Services.
Does Moichor have an API?
No public API is recorded for Moichor.
What industry is Moichor in?
Moichor's product category is Veterinary Diagnostics Software. Its primary akta.pro industry code is HLAMADAI, Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers), with a secondary code of HLAMADAA, Reference Laboratory Testing (Clinical Pathology & Chemistry). Its NAICS code is 541940 and its SIC code is 8071.